You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 1, January 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cytomegalovirus Retinitis and Acquired Immunodeficiency Syndrome

Douglas A. Jabs, MD; Cheryl Enger, MS; John G. Bartlett, MD

Arch Ophthalmol. 1989;107(1):75-80.


Abstract

• In a series of 157 patients with acquired immunodeficiency syndrome (AIDS), 46 (29%) developed cytomegalovirus (CMV) retinitis. In five patients, CMV retinitis was the initial AIDS-defining opportunistic infection (11% of patients with CMV retinitis and 3% of patients with AIDS). Retinal detachments developed in seven patients (15%) and in four were present before the institution of ganciclovir therapy. Bilateral CMV retinitis was present in 35% of patients at presentation and subsequently developed in nine (60%) of 15 patients while not being treated with ganciclovir. Conversely, none of 18 patients with unilateral disease developed bilateral disease while receiving ganciclovir. Of patients treated with ganciclovir for their CMV retinitis, 81% had a response to the drug, and 61% achieved a complete response, resulting in a nonprogressive and inactive scar. Patients who achieved a complete response with ganciclovir had a significantly longer survival than those who did not, suggesting greater immune compromise in those patients who failed to respond to ganciclovir.



Author Affiliations

From The Wilmer Ophthalmological Institute, Department of Ophthalmology (Dr Jabs and Ms Enger) and Division of Infectious Diseases, Department of Medicine (Dr Bartlett), The Johns Hopkins University School of Medicine, Baltimore.


Footnotes

Accepted for publication Aug 10, 1988.

Reprint requests to The Wilmer Ophthalmological Institute, Wilmer 300, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21205 (Dr Jabs).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The 100 Most Frequently Cited Articles in Ophthalmology Journals
Ohba et al.
Arch Ophthalmol 2007;125:952-960.
ABSTRACT | FULL TEXT  

Effect of Ganciclovir on the Hydrolytic Degradation of Poly(lactide-co-glycolide) Microspheres
Chen et al.
J Biomater Appl 2006;20:287-302.
ABSTRACT  

Risk of Vision Loss in Patients With Cytomegalovirus Retinitis and the Acquired Immunodeficiency Syndrome
Kempen et al.
Arch Ophthalmol 2003;121:466-476.
ABSTRACT | FULL TEXT  

Discontinuing anticytomegalovirus therapy in patients with cytomegalovirus retinitis and AIDS
JABS
Br J Ophthalmol 2001;85:381-382.
FULL TEXT  

Management and Prevention of Opportunistic Infections in the HIV-Infected Patient
Purdy
Journal of Pharmacy Practice 2000;13:475-498.
ABSTRACT  

Entry of Human Cytomegalovirus into Retinal Pigment Epithelial and Endothelial Cells by Endocytosis
Bodaghi et al.
IOVS 1999;40:2598-2607.
ABSTRACT | FULL TEXT  

Protection against Murine Cytomegalovirus Retinitis by Adoptive Transfer of Virus-Specific CD8+ T Cells
Bigger et al.
IOVS 1999;40:2608-2613.
ABSTRACT | FULL TEXT  

HIV medicine: Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome
Eong et al.
Postgrad. Med. J. 1999;75:585-590.
ABSTRACT | FULL TEXT  

Human Cytomegalovirus and Human Herpesvirus 6 Genes That Transform and Transactivate
Doniger et al.
Clin. Microbiol. Rev. 1999;12:367-382.
ABSTRACT | FULL TEXT  

Role of IFN-{gamma}-Induced Indoleamine 2,3 Dioxygenase and Inducible Nitric Oxide Synthase in the Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells
Bodaghi et al.
J. Immunol. 1999;162:957-964.
ABSTRACT | FULL TEXT  

Incidence of Foscarnet Resistance and Cidofovir Resistance in Patients Treated for Cytomegalovirus Retinitis
Jabs et al.
Antimicrob. Agents Chemother. 1998;42:2240-2244.
ABSTRACT | FULL TEXT  

Do all patients with CMV retinitis require life long anti-CMV therapy?
NOLAN and MITCHELL
Br J Ophthalmol 1998;82:841e-841.
FULL TEXT  

NK Cell Modulation of Murine Cytomegalovirus Retinitis
Bigger et al.
J. Immunol. 1998;160:5826-5831.
ABSTRACT | FULL TEXT  

Immune Recovery Vitritis Associated With Inactive Cytomegalovirus Retinitis: A New Syndrome
Karavellas et al.
Arch Ophthalmol 1998;116:169-175.
ABSTRACT | FULL TEXT  

MSL-109 Adjuvant Therapy for Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome: The Monoclonal Antibody Cytomegalovirus Retinitis Trial
The Studies of Ocular Complications of AIDS Resear
Arch Ophthalmol 1997;115:1528-1536.
ABSTRACT  

Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir Implant
Musch et al.
NEJM 1997;337:83-90.
ABSTRACT | FULL TEXT  

Treatment of Cytomegalovirus Retinitis in Patients with the Acquired Immunodeficiency Syndrome
Jacobson
NEJM 1997;337:105-114.
FULL TEXT  

Cidofovir
Jabs
Arch Ophthalmol 1997;115:785-786.
ABSTRACT  

Screening for Cytomegalovirus Retinitis in Children
Baumal et al.
Arch Pediatr Adolesc Med 1996;150:1186-1192.
ABSTRACT  

Ganciclovir
Crumpacker
NEJM 1996;335:721-729.
FULL TEXT  

Cytomegalovirus Retinitis and Viral Resistance: Prevalence of Resistance at Diagnosis, 1994
Jabs et al.
Arch Ophthalmol 1996;114:809-814.
ABSTRACT  

Measuring Visual Function and Quality of Life in Patients With Cytomegalovirus Retinitis: Development of a Questionnaire
Wu et al.
Arch Ophthalmol 1996;114:841-847.
ABSTRACT  

Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Persons with AIDS
Spector et al.
NEJM 1996;334:1491-1497.
ABSTRACT | FULL TEXT  

Referral Patterns of Uveitis in a Tertiary Eye Care Center
Rodriguez et al.
Arch Ophthalmol 1996;114:593-599.
ABSTRACT  

Ocular Manifestations of AIDS
Whitcup
JAMA 1996;275:142-144.
ABSTRACT  

Combination Foscarnet and Ganciclovir Therapy vs Monotherapy for the Treatment of Relapsed Cytomegalovirus Retinitis in Patients With AIDS: The Cytomegalovirus Retreatment Trial
The Studies of Ocular Complications of AIDS Resear
Arch Ophthalmol 1996;114:23-33.
ABSTRACT  

Silicone Oil in Repair of Retinal Detachments Caused by Necrotizing Retinitis in HIV Infection
Davis et al.
Arch Ophthalmol 1995;113:1401-1409.
ABSTRACT  

Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDS
Drew et al.
NEJM 1995;333:615-620.
ABSTRACT | FULL TEXT  

Long-term Therapy for Herpes Retinitis in an Animal Model With High-Concentrated Liposome-Encapsulated HPMPC
Besen et al.
Arch Ophthalmol 1995;113:661-668.
ABSTRACT  

Morbidity and Toxic Effects Associated With Ganciclovir or Foscarnet Therapy in a Randomized Cytomegalovirus Retinitis Trial
Studies of Ocular Complications of AIDS Research G et al.
Arch Intern Med 1995;155:65-74.
ABSTRACT  

Treatment of Cytomegalovirus Retinitis With an Intraocular Sustained-Release Ganciclovir Implant: A Randomized Controlled Clinical Trial
Martin et al.
Arch Ophthalmol 1994;112:1531-1539.
ABSTRACT  

Diseases of the Retina
D'Amico
NEJM 1994;331:95-106.
FULL TEXT  

The Eye in Bone Marrow Transplantation: VI. Retinal Complications
Coskuncan et al.
Arch Ophthalmol 1994;112:372-379.
ABSTRACT  

Combination Ganciclovir and Foscarnet in the Treatment of Clinically Resistant Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome
Kuppermann et al.
Arch Ophthalmol 1993;111:1359-1366.
ABSTRACT  

Control of Cytomegalovirus Retinitis Using Sustained Release of Intraocular Ganciclovir
Anand et al.
Arch Ophthalmol 1993;111:223-227.
ABSTRACT  

Progression Rates of Cytomegalovirus Retinopathy in Ganciclovir-Treated and Untreated Patients
Holland and Shuler
Arch Ophthalmol 1992;110:1435-1442.
ABSTRACT  

Ophthalmology
O'Brien and Goldberg
JAMA 1992;268:393-395.
ABSTRACT  

Treatment of Cytomegalovirus Retinitis--1992
Jabs
Arch Ophthalmol 1992;110:185-187.
ABSTRACT  

Sustained-Release Ganciclovir Therapy for Treatment of Cytomegalovirus Retinitis: Use of an Intravitreal Device
Sanborn et al.
Arch Ophthalmol 1992;110:188-195.
ABSTRACT  

Ocular Manifestations of AIDS
de Smet and Nussenbatt
JAMA 1991;266:3019-3022.
ABSTRACT  

Retinal Detachments in Patients With Cytomegalovirus Retinitis
Jabs et al.
Arch Ophthalmol 1991;109:794-799.
ABSTRACT  

Cytomegalovirus Retinitis
To and Friedman
JAMA 1989;262:3337-3337.
ABSTRACT  

Intraocular Antiviral Therapy
Freeman
Arch Ophthalmol 1989;107:1737-1739.
ABSTRACT  

A Controlled Retrospective Study of Ganciclovir Treatment for Cytomegalovirus Retinopathy: Use of a Standardized System for the Assessment of Disease Outcome
Holland et al.
Arch Ophthalmol 1989;107:1759-1766.
ABSTRACT  

Long-term Intravitreal Ganciclovir Therapy for Cytomegalovirus Retinopathy
Heinemann
Arch Ophthalmol 1989;107:1767-1772.
ABSTRACT  

Regression of Cytomegalovirus Retinitis With Zidovudine: A Clinicopathologic Correlation
Guyer et al.
Arch Ophthalmol 1989;107:868-874.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.